{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:57:47Z","timestamp":1783645067601,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The optimal route of antimicrobial administration for preseptal orbital cellulitis (OC) in children remains uncertain. While mild cases may be managed with oral therapy, distinguishing between mild and severe presentations is challenging. The recently proposed ASSET score offers a tool for assessing the severity of skin and soft tissue infections, but prospective validation in large cohorts of preseptal OC is lacking. As a result, most patients with periorbital infections are admitted for intravenous (IV) antibiotics. This study aims to identify clinical and laboratory features predictive of severe preseptal OC requiring IV treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective study was conducted at Meyer Children\u2019s Hospital IRCCS, Florence, reviewing outpatient records for OC cases from January 2017 to June 2024. Data on age, sex, clinical presentation, blood tests, and management were collected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Previously initiated oral therapy was associated with the need for IV therapy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), as well as the presence of fever (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and severe eyelid swelling (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The median ASSET score was higher in patients with preseptal OC requiring IV therapy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Differences in laboratory findings were noted between children with preseptal OC managed with and without IV antibiotics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Previous trials of oral antibiotics, systemic features, and severe swelling influence clinicians\u2019 decisions to initiate IV antibiotics in preseptal OC. If validated for preseptal OC, the application of the ASSET score could significantly reduce the number of children treated with IV antibiotics. Ancillary blood tests may be useful for detecting preseptal OC requiring IV treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13052-025-01931-x","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T17:01:06Z","timestamp":1750006866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis"],"prefix":"10.1186","volume":"51","author":[{"given":"Roberto","family":"Privato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Inserra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chiappini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7912-3366","authenticated-orcid":false,"given":"Luisa","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,15]]},"reference":[{"issue":"4","key":"1931_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.survophthal.2017.12.00","volume":"63","author":"T - Tsirouki","year":"2018","unstructured":"- Tsirouki T, Dastiridou AI, Ib\u00e1nez flores N, et al. Orbital cellulitis. Surv Ophthalmol. 2018;63(4):534\u201353. https:\/\/doi.org\/10.1016\/j.survophthal.2017.12.00","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"1931_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/jama.2019.18211","volume":"323","author":"I - Baiu","year":"2020","unstructured":"- Baiu I, Melendez E, Periorbital, Cellulitis O. JAMA. 2020;323(2):196. https:\/\/doi.org\/10.1001\/jama.2019.18211","journal-title":"JAMA"},{"key":"1931_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00004397-200110000-00009","volume":"41","author":"A - Jain","year":"2001","unstructured":"- Jain A, Rubin PA. Orbital cellulitis in children. Int Ophthalmol Clin. 2001;41:71\u201386.","journal-title":"Int Ophthalmol Clin"},{"key":"1931_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ijporl.2007.11.013","volume":"72","author":"AM - Botting","year":"2008","unstructured":"- Botting AM, McIntosh D, Mahadevan M. Paediatric pre- and post-septal peri-orbital infections are different diseases: A retrospective review of 262 cases. Int J Pediatr Otorhinolaryngol. 2008;72:377\u201383.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1931_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/01.inf.0000227820.36036.f1","volume":"25","author":"S - Nageswaran","year":"2006","unstructured":"- Nageswaran S, Woods CR, Benjamin DK, et al. Orbital cellulitis in children. Pediatr Infect Dis J. 2006;25:695\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"1931_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijporl.2018.05.006","volume":"110","author":"SJ - Wong","year":"2018","unstructured":"- Wong SJ, Levi J. Management of pediatric orbital cellulitis: a systematic review. Int J Pediatr Otorhinolaryngol. 2018;110:123\u20139.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1","key":"1931_CR7","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1542\/peds.2013-1071","volume":"132","author":"ER - Wald","year":"2013","unstructured":"- Wald ER, Applegate KE, Bordley C, et al. American academy of pediatrics. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013;132(1):e262\u201380. https:\/\/doi.org\/10.1542\/peds.2013-1071","journal-title":"Pediatrics"},{"issue":"3","key":"1931_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/eye.2008.44","volume":"23","author":"PS - Cannon","year":"2009","unstructured":"- Cannon PS, Mc Keag D, Radford R, et al. Our experience using primary oral antibiotics in the management of orbital cellulitis in a tertiary referral centre. Eye. 2009;23(3):612\u20135. 10.1038\/ eye.2008.44.","journal-title":"Eye"},{"key":"1931_CR9","doi-asserted-by":"publisher","first-page":"e719","DOI":"10.1542\/peds.2009-1709","volume":"125","author":"TF - Rudloe","year":"2010","unstructured":"- Rudloe TF, Harper MB, Prabhu SP, et al. Acute periorbital infections: who needs emergent imaging? Pediatrics. 2010;125:e719\u201326.","journal-title":"Pediatrics"},{"key":"1931_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijporl.2019.02.003","volume":"120","author":"JC - Santos","year":"2019","unstructured":"- Santos JC, Pinto S, Ferreira S, et al. Pediatric preseptal and orbital cellulitis: a 10-year experience. Int J Pediatr Otorhinolaryngol. 2019;120:82\u20138.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"10","key":"1931_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1473-3099(19)30288-9","volume":"19","author":"LF - Ibrahim","year":"2019","unstructured":"- Ibrahim LF, Huang L, Hopper SM, et al. Intravenous ceftriaxone at home versus intravenous Flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis. Lancet Infect Dis. 2019;19(10):1101\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(19)30288-9. Epub 2019 Aug 13. PMID: 31420292.","journal-title":"Lancet Infect Dis"},{"key":"1931_CR12","doi-asserted-by":"publisher","unstructured":"- Ibrahim LF, Hopper SM, Donath S, et al. Development and validation of a cellulitis risk score: the Melbourne ASSET score. Pediatr Febr. 2019;143(2):e20181420. https:\/\/doi.org\/10.1542\/peds.2018","DOI":"10.1542\/peds.2018"},{"key":"1931_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/archdischild-2020-320590","volume":"106","author":"LF - Ibrahim","year":"2021","unstructured":"- Ibrahim LF, Babl FE, Hopper SM, et al. What is the risk of missing orbital cellulitis in children? Arch Dis Child. 2021;106:896\u20139.","journal-title":"Arch Dis Child"},{"key":"1931_CR14","doi-asserted-by":"publisher","unstructured":"- Bystritsky RJ, Cellulitis. Infect Dis Clin North Am. 2021;35(1):49\u201360. https:\/\/doi.org\/10.1016\/j.idc.2020.10.002. PMID: 33494874.","DOI":"10.1016\/j.idc.2020.10.002"},{"key":"1931_CR15","doi-asserted-by":"publisher","unstructured":"- Yadav K, Suh KN, Eagles D et al. Predictors of Oral Antibiotic Treatment Failure for Nonpurulent Skin and Soft Tissue Infections in the Emergency Department. Acad Emerg Med. 2019;26(1):51\u201359. https:\/\/doi.org\/10.1111\/acem.13492. Epub 2018 Jul 4. PMID: 29869364.","DOI":"10.1111\/acem.13492"},{"key":"1931_CR16","volume-title":"Acute bacterial skin and skin structure infections: developing drugs for treatment","author":"- Guidance for Industry","year":"2013","unstructured":"- Guidance for Industry. Acute bacterial skin and skin structure infections: developing drugs for treatment. Silver Spring (MD): U.S. Food and Drug Admin. 2013."},{"issue":"3","key":"1931_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1017\/cem.2016.347","volume":"19","author":"K - Yadav","year":"2017","unstructured":"- Yadav K, Gatien M, Corrales-Medina V, et al. Antimicrobial treatment decision for non-purulent skin and soft tissue infections in the emergency department. CJEM. 2017;19(3):175\u201380. https:\/\/doi.org\/10.1017\/cem.2016.347. Epub 2016 Aug 17. PMID: 27531595.","journal-title":"CJEM"},{"key":"1931_CR18","doi-asserted-by":"publisher","unstructured":"- Ohana-Sarna-Cahan L, Hurvitz N, Gross I et al. Factors Associated With Increased Risk of Pediatric Orbital Cellulitis-Who Should Be Scanned? Pediatr Emerg Care. 2021;37(12):e1473-e1477. https:\/\/doi.org\/10.1097\/PEC.0000000000002083. PMID: 32205800.","DOI":"10.1097\/PEC.0000000000002083"},{"key":"1931_CR19","unstructured":"- Ohana-Sarna-Cahan L, Hurvitz N, Gross I, Feasson T, Debeaupte M, Bidet C et al. Feasson, T., Debeaupte, M., Bidet, C. Impact of anti-inflammatory drug consumption in peritonsillar abscesses: a retrospective cohort study. BMC Infect Dis. 2016:16432."},{"issue":"3","key":"1931_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2230.2007.02652.x","volume":"33","author":"C - Souyri","year":"2008","unstructured":"- Souyri C, Olivier P, Grolleau S, et al. French network of pharmacovigilance centres. Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clin Exp Dermatol. 2008;33(3):249\u201355. https:\/\/doi.org\/10.1111\/j.1365-2230.2007.02652.x. Epub 2008 Feb 2. PMID: 18261144.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"1931_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ajem.2019.10.023","volume":"38","author":"Z - Huang","year":"2020","unstructured":"- Huang Z, Fu Z, Huang W, et al. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. Am J Emerg Med. 2020;38(3):641\u20137. https:\/\/doi.org\/10.1016\/j.ajem.2019.10.023. Epub 2019 Nov 18. PMID: 31785981.","journal-title":"Am J Emerg Med"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01931-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01931-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01931-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T17:01:07Z","timestamp":1750006867000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01931-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1931"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01931-x","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,15]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Pediatric Ethic Committee of Tuscany Region, Italy (study protocol 207\/2024; approved on the 8 October 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}